Crystal structure of UBE2G2 adduct with phenethyl isothiocyanate (PEITC) at the Cys48 position
Wang, C., Shaw, G.X., Shi, G., Ji, X.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Ubiquitin-conjugating enzyme E2 G2 | 165 | Homo sapiens | Mutation(s): 2  Gene Names: UBE2G2, UBC7 EC: 2.3.2.23 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P60604 (Homo sapiens) Explore P60604  Go to UniProtKB:  P60604 | |||||
PHAROS:  P60604 GTEx:  ENSG00000184787  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P60604 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
E3 ubiquitin-protein ligase AMFR | 27 | Homo sapiens | Mutation(s): 0  EC: 2.3.2.36 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q9UKV5 (Homo sapiens) Explore Q9UKV5  Go to UniProtKB:  Q9UKV5 | |||||
PHAROS:  Q9UKV5 GTEx:  ENSG00000159461  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q9UKV5 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
EDO Query on EDO | C [auth A] | 1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N |
Modified Residues 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Type | Formula | 2D Diagram | Parent |
6M6 Query on 6M6 | A | L-PEPTIDE LINKING | C12 H16 N2 O2 S2 | CYS |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 47.894 | α = 90 |
b = 59.345 | β = 90 |
c = 67.901 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
SCALEPACK | data scaling |
DENZO | data reduction |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Cancer Institute (NIH/NCI) | United States | Intramural Research Program |